Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of icosl protein in preparation of breast cancer prognosis assessment kit

A technology for prognostic assessment and breast cancer, which is applied in the biological field and can solve the problems of breast cancer cell ICOSL that have not been reported.

Active Publication Date: 2021-12-21
SHANGHAI CHANGHAI HOSPITAL
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] So far, there is no report on the expression of ICOSL in breast cancer cells and its relationship with prognosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of icosl protein in preparation of breast cancer prognosis assessment kit
  • Application of icosl protein in preparation of breast cancer prognosis assessment kit
  • Application of icosl protein in preparation of breast cancer prognosis assessment kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] The present invention employs immunohistochemistry ICOSL relative expression of the protein in breast cancer detection, the specific steps:

[0067] (1) Preparation of paraffin sections of breast cancer tissues, 60 ℃ oven overnight;

[0068] (2) to the water dewaxing slice;

[0069] (①10min → Xylene Xylene Xylene ②10min → ethanol ③10min → 100% ethanol 5min → 95% ethanol 5min → 85% ethanol 5min → 75% double distilled water 5min 5min →)

[0070] (3) 3% H 2 O 2 Methanol solution, room temperature for 20min;

[0071] (4) distilled water 5min × 3;

[0072] (5) Antigen Retrieval: sections were placed in 0.01M citrate buffer (pH 6.0) boiled for 5min, cease-fire 10min, then boiled for 5min;

[0073] (6) cool to room temperature, distilled water 5min × 3;

[0074] (7) 1% BSA blocking 30min, 37 ℃;

[0075] (8) the rejection to the blocking solution, washing is not directly primary antibody (Anti-ICOS Ligand antibody [2D3] ab189052, ABCAM Company). Wet box placed 30min, 37 ℃, 4 ℃ refr...

Embodiment 2

[0089] Experimental Materials: 2003-2010 Shanghai Changhai Hospital, next to the 162 cases of invasive breast cancer surgical specimens and normal tissue samples

[0090] Method: breast cancer tissue specimens and adjacent normal tissue ICOSL performed according to the method of Example 1 staining embodiment, as described above for the expression of ICOSL film score.

[0091] Result: figure 1 And shown in Table 1, 162 cases of breast cancer and their adjacent corresponding cancer tissues were analyzed for expression of ICOSL, appears next ICOSL cancer positive rate significantly higher than carcinoma.

[0092] Table 1: cancer tissue than the corresponding adjacent tissues ICOSL positive rate and expression level raised

[0093]

Embodiment 3

[0095] Experimental Materials: 2003-2010 next to Changhai Hospital, 121 cases of invasive breast cancer surgical specimens and normal tissue samples

[0096] Method: Postoperative treatment is performed in accordance with the scheme recommended by the NCCN Guide, and follows the time of survival time, considering the expression of ICOSL, and age, pathological type, pathological grading, Er, PR, HER2 and other factors, 121 cases Analysis of multivariate COX proportional risk model for patients with breast cancer patients.

[0097] RESULTS: As shown in Table 2, the factors such as age, pathological type, pathological grading, Er, PR, HER2, and breast cancer cells were expressed in breast cancer independent prognostic factors.

[0098] Table 2: Multi-factor analysis of the expression of ICOSL in consideration of age, pathological type, pathological grading, Er, PR, HER2, etc.

[0099]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biotechnology, in particular to the application of ICOSL protein in the preparation of breast cancer prognosis assessment kits. The beneficial effect of the present invention is that: the present invention utilizes immunohistochemistry technique, staining result semi-quantitative analysis method, analyzes the expression level of tumor tissue ICOSL protein, and combines postoperative follow-up information, determines whether ICOSL protein expression is related to the prognosis of breast cancer patients. There is a correlation, and the ICOSL protein can be used to prepare protein molecular markers for judging the prognosis of breast cancer patients, and it also has important guiding significance for postoperative monitoring and sequential treatment of breast cancer patients.

Description

Technical field [0001] The present invention relates to the field of biotechnology, in particular to ICOSL (Inducible Costimulator, inducible co-stimulating molecular ligand; also known as B7H2) protein in the preparation of breast cancer prognostic evaluation kits. Background technique [0002] Breast cancer is also the case in the world only in the second most common tumor (11.6%) of lung cancer, which is the most common malignant tumor in my country. Breast cancer, especially triple-negative breast cancer (ER, PR, HER2 expression is negative) is high, invasive, easy to recuriate and metastasis, and severely affects the survival of patients with breast cancer. The type of breast cancer accounts for about 10-15% of all breast cancer, due to its estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (Her2) are negative (three negative), There is currently no clear treatment of targets, and the 5-year survival rate is less than 15%. [0003] Brea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/574G01N33/535
CPCG01N33/57415G01N33/535
Inventor 王斌马宁湛先保李洁彭小波吴梅红
Owner SHANGHAI CHANGHAI HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com